Proteome Sciences Share Discussion Threads

[peverill] 27/1/2023 10:36

Was more interested in where this "IMMINENT" stroke test was,but thanks for the heads up.I am sure a couple of weeks was mentioned on here a while back!!!!.

[monte1] 27/1/2023 08:38

Too right matey.

Wouldn’t want to risk ending up like you.

vbrs

[goatherd] 27/1/2023 08:36

I suppose you guys will never grow up.

[monte1] 27/1/2023 08:27

The olde freebb round numbers game pev.

[dominiccummings] 19/1/2023 22:12

Experience will win of course.

[james japp] 19/1/2023 19:37

Arraws monte1.

[canaletto] 19/1/2023 19:35

Oh man I missed it

[canaletto] 19/1/2023 18:57

Then go and see Chris himself. He will be there.

[peverill] 19/1/2023 17:22

What to listen to her reading off another CJP script as every other CEO has done,no thanks.

[canaletto] 19/1/2023 10:33

You can go Neely to belly with her at the AGM Pev. Ask her directly

[peverill] 19/1/2023 10:15

I would be more interested in where is Mariola and what she is upto,not convinced at all.2 years in and sfa.

[canaletto] 19/1/2023 09:57

When is the AGM?

[peverill] 16/1/2023 18:57

You peddled it enough over the years.Peter had you hook,line and sinker if you remember back that far.

[bluemango] 16/1/2023 17:49

Absolutely. Of course 'the market' is ignoring PRM.

Because it's heard it all before! As has been pointed out ad nauseum. Much as I respect jeffian, he and others ignore this every time they talk about things being 'already priced in'.

[goatherd] 16/1/2023 17:33

Jeffian,

If Randox is seeing strong interest in their stroke test then surely it looks as if it will get to market?

The test will run on Randox's "Evidence Multistat" which is primarily a drug testing device and, as such, is available in a rather large percentage of hospitals both here and in the USA. This obviously makes selling easier. (Just the test; not the machine).

The penultimate CEO of Proteome confirmed to me (by email) that Proteome would earn "double digit" royalties from the stroke test. By which I assume he meant at least 10%.

I don't actually think "the market" is paying any attention to Proteome, do you?

[jeffian] 16/1/2023 15:41

This is all rather reminiscent of the 'last tree standing' hullaballoo about TMT which was supposed to release a wave of cash for PRM but actually gained traction extremely slowly and, even today, hardly qualifies PRM as a 'growth stock'. The stages that the Randox stroke test have to go through are, firstly, that it has to get to market, secondly, that it has to gain widespread adoption by the NHS and other healthcare services and, thirdly, that we actually see the cash benefit to PRM. Given that the Randox information is all in the public domain, one might imagine that whatever benefit the market ascribes to it is already in the price.

[goatherd] 16/1/2023 15:33

You still believe that then peverill?

[peverill] 16/1/2023 15:29

And GE's NDA.

[james japp] 16/1/2023 14:08

Dont forget the phone lines in Ireland.

[monte1] 16/1/2023 14:02

Tsunamis notwithstanding natch.

[monte1] 16/1/2023 14:01

Imminently?